ITP Is More Than a Platelet Count: Why Patient Perspectives Matter – ITP Australia and New Zealand
ITP Australia and New Zealand shared a post on LinkedIn:
”What if we stopped asking, ‘How are your platelet counts?’ and started asking, ‘How are you?’
At the recent Blood 2026 ITP and PNH Symposium, our CEO, Danielle Boyle, who has lived with ITP for more than a decade, joined international experts to discuss the realities of living with ITP beyond the blood test results.
One message stood out clearly:
ITP is more than a platelet count.
Many patients leave appointments wanting to discuss:
- Fatigue and energy levels
- The impact of treatment on daily life
- Work, study, and family responsibilities
- Mental wellbeing and uncertainty
- Personal goals and priorities
- The things that matter most to them as individuals
The challenge is that these conversations don’t always happen.
The ‘4 Questions for Healthcare Professionals’ resource encourages a broader discussion during consultations and helps ensure patient-centred care extends beyond laboratory values and bleeding symptoms.
Because understanding:
- how a patient is functioning
- how they are coping
- what their goals are
- what challenges they are facing
is often just as important as understanding their latest platelet count.
For healthcare professionals, researchers, and industry partners, it is a timely reminder that meaningful care begins with meaningful conversations.
What is one question you think healthcare professionals should be asking more often when supporting people living with chronic conditions such as ITP?”

Stay updated with Hemostatis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian